News
- Author:
- Deborah Brauser
Publish date: November 27, 2024
While the study is important — especially because it highlights inhalation as a viable route of entry — exposure through the olfactory area is stil...
News
- Author:
- Deborah Brauser
Publish date: October 29, 2024
The therapy allows patients to interact with a “digital embodiment” of the voice they hear, which is represented by a computer-generated face, also...
News
- Author:
- Deborah Brauser
Publish date: October 15, 2024
As do-it-yourself (DIY) brain stimulation devices gain popularity for common psychiatric conditions, questions ar...
News
- Author:
- Deborah Brauser
Publish date: August 22, 2024
While quantifying the exact increase in risk is challenging, “there’s no doubt about it; it’s not trivial.”
News
- Author:
- Deborah Brauser
Publish date: August 7, 2024
ECT is primarily used for treatment-resistant depression and is effective in up to 80% of patients, yet it remains one of the least prescribed trea...
News
- Author:
- Deborah Brauser
Publish date: January 31, 2022
“I think this is an approach that works, and this study makes that clear,” said Dr. Geert Jan Groeneveld.
News
- Author:
- Deborah Brauser
Publish date: August 18, 2021
The neurostimulation system has previously received FDA approval for refractory depression, obsessive-compulsive disorder, and smoking addiction.
News
- Author:
- Deborah Brauser
Publish date: August 18, 2021
On July 2, the FDA reported that Pfizer had voluntarily recalled nine lots of the drug.
News
- Author:
- Deborah Brauser
Publish date: July 12, 2021
An independent investigation will examine whether anything occurred that was “inconsistent with FDA policies and procedures.”
News
- Author:
- Deborah Brauser
Publish date: June 25, 2021
In view of the “fierce public debate” that erupted immediately following the drug’s approval, the FDA felt compelled to explain how it reached its ...
News
- Author:
- Deborah Brauser
Publish date: June 7, 2021
Approval was granted despite an FDA advisory panel recommendation not to approve the drug.
News
- Author:
- Deborah Brauser
Publish date: May 7, 2021
All three doses of the novel agent were associated with significant improvements in sleep quality, refreshing nature of sleep, sleep paralysis, dis...
News
- Author:
- Deborah Brauser
Publish date: April 30, 2021
“The risk of CVST due to infection with COVID-19 is 8-10 times higher than the risk of CVST after receiving a COV...
News
- Author:
- Deborah Brauser
Publish date: April 26, 2021
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
News
- Author:
- Deborah Brauser
Publish date: April 20, 2021
These findings may have implications for the way Black patients with autoimmune diseases are treated in the future.
